Catalyst Wire Dossier Catalyst Wire Dossier

Shigella bioconjugate vaccine (GlycoVaxyn)

Shigella bioconjugate vaccine · GlycoVaxyn AG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Shigella bioconjugate vaccine (GlycoVaxyn), covering 2010-10-13 to 2010-10-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Reactogenicity of Bioconjugate Vaccine to Prevent Shigella [Phase 1]

See pricing